RYTM
Price
$66.18
Change
+$1.79 (+2.78%)
Updated
Jun 5 closing price
Capitalization
4.21B
60 days until earnings call
TARS
Price
$44.08
Change
+$1.43 (+3.35%)
Updated
Jun 5 closing price
Capitalization
1.85B
62 days until earnings call
Interact to see
Advertisement

RYTM vs TARS

Header iconRYTM vs TARS Comparison
Open Charts RYTM vs TARSBanner chart's image
Rhythm Pharmaceuticals
Price$66.18
Change+$1.79 (+2.78%)
Volume$690.9K
Capitalization4.21B
Tarsus Pharmaceuticals
Price$44.08
Change+$1.43 (+3.35%)
Volume$811.57K
Capitalization1.85B
RYTM vs TARS Comparison Chart
Loading...
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
RYTM vs. TARS commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RYTM is a Buy and TARS is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (RYTM: $66.18 vs. TARS: $44.08)
Brand notoriety: RYTM and TARS are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: RYTM: 88% vs. TARS: 122%
Market capitalization -- RYTM: $4.21B vs. TARS: $1.85B
RYTM [@Biotechnology] is valued at $4.21B. TARS’s [@Biotechnology] market capitalization is $1.85B. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

RYTM’s FA Score shows that 1 FA rating(s) are green whileTARS’s FA Score has 0 green FA rating(s).

  • RYTM’s FA Score: 1 green, 4 red.
  • TARS’s FA Score: 0 green, 5 red.
According to our system of comparison, RYTM is a better buy in the long-term than TARS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

RYTM’s TA Score shows that 4 TA indicator(s) are bullish while TARS’s TA Score has 7 bullish TA indicator(s).

  • RYTM’s TA Score: 4 bullish, 3 bearish.
  • TARS’s TA Score: 7 bullish, 3 bearish.
According to our system of comparison, TARS is a better buy in the short-term than RYTM.

Price Growth

RYTM (@Biotechnology) experienced а +6.95% price change this week, while TARS (@Biotechnology) price change was +1.47% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.85%. For the same industry, the average monthly price growth was +10.46%, and the average quarterly price growth was -0.86%.

Reported Earning Dates

RYTM is expected to report earnings on Aug 05, 2025.

TARS is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+7.85% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RYTM($4.21B) has a higher market cap than TARS($1.85B). RYTM YTD gains are higher at: 18.221 vs. TARS (-20.390). TARS has higher annual earnings (EBITDA): -94.96M vs. RYTM (-145.8M). TARS has more cash in the bank: 408M vs. RYTM (314M). RYTM has less debt than TARS: RYTM (4.06M) vs TARS (72.4M). TARS has higher revenues than RYTM: TARS (234M) vs RYTM (137M).
RYTMTARSRYTM / TARS
Capitalization4.21B1.85B227%
EBITDA-145.8M-94.96M154%
Gain YTD18.221-20.390-89%
P/E RatioN/AN/A-
Revenue137M234M59%
Total Cash314M408M77%
Total Debt4.06M72.4M6%
FUNDAMENTALS RATINGS
RYTM: Fundamental Ratings
RYTM
OUTLOOK RATING
1..100
11
VALUATION
overvalued / fair valued / undervalued
1..100
97
Overvalued
PROFIT vs RISK RATING
1..100
32
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
42
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
RYTMTARS
RSI
ODDS (%)
N/A
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
86%
Bullish Trend 1 day ago
71%
MACD
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
88%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
75%
Bearish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
83%
Declines
ODDS (%)
Bearish Trend 16 days ago
80%
Bearish Trend 11 days ago
82%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
80%
Aroon
ODDS (%)
Bullish Trend 1 day ago
75%
Bullish Trend 1 day ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
RYTM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TARS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EVG10.810.01
+0.14%
Eaton Vance Short Duration Diversified Income Fund
DIVI35.510.05
+0.14%
Franklin Intl Core Div Tlt Idx ETF
ISHG74.760.06
+0.08%
iShares 1-3 Year International TrsBd ETF
SUPL37.57N/A
N/A
ProShares Supply Chain Logistics ETF
GNOM8.11-0.03
-0.36%
Global X Genomics & Biotechnology ETF

TARS and

Correlation & Price change

A.I.dvisor indicates that over the last year, TARS has been loosely correlated with ADMA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if TARS jumps, then ADMA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TARS
1D Price
Change %
TARS100%
+3.35%
ADMA - TARS
43%
Loosely correlated
-1.92%
RYTM - TARS
40%
Loosely correlated
+2.77%
CRNX - TARS
38%
Loosely correlated
+0.59%
ETNB - TARS
36%
Loosely correlated
-0.99%
DNTH - TARS
35%
Loosely correlated
+3.12%
More